OBJECTIVE: To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancer patients. SUMMARY BACKGROUND DATA: Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancer patients, suggesting that this proteolytic system might be modulated also in human cancer. METHODS: Biopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancer patients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed. RESULTS: Muscle ubiquitin mRNA was hyperexpressed in gastric cancer patients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancer patients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity. CONCLUSIONS: These results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancer patients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed.
OBJECTIVE: To investigate the state of activation of the ATP-ubiquitin-dependent proteolytic system in the skeletal muscle of gastric cancerpatients. SUMMARY BACKGROUND DATA: Muscle wasting in experimental cancer cachexia is frequently associated with hyperactivation of the ATP-dependent ubiquitin-proteasome proteolytic system. Increased muscle ubiquitin mRNA levels have been previously shown in gastric cancerpatients, suggesting that this proteolytic system might be modulated also in humancancer. METHODS: Biopsies of the rectus abdominis muscle were obtained intraoperatively from 23 gastric cancerpatients and 14 subjects undergoing surgery for benign abdominal diseases, and muscle ubiquitin mRNA expression and proteasome proteolytic activities were assessed. RESULTS: Muscle ubiquitin mRNA was hyperexpressed in gastric cancerpatients compared to controls. In parallel, three proteasome proteolytic activities (CTL, chymotrypsin-like; TL, trypsin-like; PGP, peptidyl-glutamyl-peptidase) significantly increased in gastric cancerpatients with respect to controls. Advanced tumor stage, poor nutritional status, and age more than 50 years were associated with significantly higher CTL activity but had no influence on TL and PGP activity. CONCLUSIONS: These results confirm the involvement of the ubiquitin-proteasome proteolytic system in the pathogenesis of muscle protein hypercatabolism in cancer cachexia. The observation that perturbations of this pathway in gastric cancerpatients occur even before clinical evidence of body wasting supports the thinking that specific pharmacologic and metabolic approaches aimed at counteracting the upregulation of this pathway should be undertaken as early as cancer is diagnosed.
Authors: M Llovera; N Carbó; C García-Martínez; P Costelli; L Tessitore; F M Baccino; N Agell; G J Bagby; F J López-Soriano; J M Argilés Journal: Biochem Biophys Res Commun Date: 1996-04-25 Impact factor: 3.575
Authors: O Mansoor; B Beaufrere; Y Boirie; C Ralliere; D Taillandier; E Aurousseau; P Schoeffler; M Arnal; D Attaix Journal: Proc Natl Acad Sci U S A Date: 1996-04-02 Impact factor: 11.205
Authors: M Bossola; M Muscaritoli; P Costelli; R Bellantone; F Pacelli; S Busquets; J Argilès; F J Lopez-Soriano; I M Civello; F M Baccino; F Rossi Fanelli; G B Doglietto Journal: Am J Physiol Regul Integr Comp Physiol Date: 2001-05 Impact factor: 3.619
Authors: G Tiao; S Hobler; J J Wang; T A Meyer; F A Luchette; J E Fischer; P O Hasselgren Journal: J Clin Invest Date: 1997-01-15 Impact factor: 14.808
Authors: M Bossola; M Muscaritoli; R Bellantone; F Pacelli; A Cascino; A Sgadari; F Battaglia; E Piccioni; G Scambia; G B Doglietto; F Rossi Fanelli Journal: Eur J Clin Invest Date: 2000-12 Impact factor: 4.686
Authors: Shuichi Sato; Song Gao; Melissa J Puppa; Matthew C Kostek; L Britt Wilson; James A Carson Journal: Med Sci Sports Exerc Date: 2019-09 Impact factor: 5.411
Authors: Aminah Jatoi; Steven R Alberts; Nathan Foster; Roscoe Morton; Patrick Burch; Margaret Block; Phuong L Nguyen; John Kugler Journal: Support Care Cancer Date: 2005-03-10 Impact factor: 3.603
Authors: Nathan A Stephens; Iain J Gallagher; Olav Rooyackers; Richard J Skipworth; Ben H Tan; Troels Marstrand; James A Ross; Denis C Guttridge; Lars Lundell; Kenneth C Fearon; James A Timmons Journal: Genome Med Date: 2010-01-15 Impact factor: 11.117